Results 91 to 100 of about 765,531 (338)

Total cost of ownership purchasing of a service : the case of airline slection at Alcatel Bell. [PDF]

open access: yes
The multiple objective problem of purchasing for business falls into two broad categories: the purchasing of components for manufacturing and the purchasing of services.
Degraeve, Zeger   +2 more
core  

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Impact of hospital characteristics on patients’ experience of hospital care: Evidence from 14 states, 2009-2011

open access: yesPatient Experience Journal, 2015
This paper uses patient responses to the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey for three years (2009-2011) from 1,333 acute-care hospitals in fourteen states to analyze patterns in 10 hospital-reported patient ...
Emily Johnston   +8 more
doaj  

Analisis Pengaruh Labelisasi Halal terhadap Keputusan Pembelian Produk Makanan Impor dalam Kemasan pada Mahasiswa Kedokteran Universitas Sumatera Utara [PDF]

open access: yes, 2013
This wacthfulness internal issue formulation how does influence labeling rightful towards import food product purchasing decision in package in field University of North Sumatra.
Sari, D. K. (Dewi)   +1 more
core  

Heterozygous loss‐of‐function alleles associate the conserved 3′‐5′ exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5‐fluorouracil

open access: yesMolecular Oncology, EarlyView.
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain   +10 more
wiley   +1 more source

How to Communicate Value Added Care: Negotiation and Saying No

open access: yesMedEdPORTAL, 2014
Introduction Educators have recently been challenged to actively incorporate instruction that emphasizes value-added care into the curriculum in a meaningful manner. This workshop defines value-added care, its importance for the practice of medicine, and
Pamela Duke, Nan Cochran
doaj   +1 more source

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

open access: yesMolecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen   +9 more
wiley   +1 more source

Value-Based Purchasing

open access: yesNursing Management, 2013
Sara, Thomas, Margaret, O'Kane
  +6 more sources

PENGARUH PROMOSI DAN BRAND IMAGE TERHADAP KEPUTUSAN PEMBELIAN PRODUK SCARLETT PADA MARKETPLACE SHOPEE

open access: yesJournal of Management and Accounting
There has been a significant increase in the level of public consumption of goods and services, with the transition of public spending from offline to online, because shopping online is easier, faster and cheaper.
Suyitno Suyitno   +2 more
doaj   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy